ABVC BioPharma, Inc. (ABVC)

R&D Expense Growth

-32.46%

Fiscal year · Period ending:

ABVC logo

ABVC R&D Expense Growth

Latest reported-32.46%
ABVC FY R&D Growth (YoY) (0.00% → -32.46%)
High-resolution chart · PNG

ABVC r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

ABVC BioPharma, Inc. R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-32.4574%
-83.1339%
-60.5371%
168.3247%
82.6236%
-47.5794%
6.0515%
-68.8264%
-68.2834%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.